Syndrome of inappropriate antidiuretic hormone secretion induced by a single dose of oral cyclophosphamide

Annals of Pharmacotherapy

Volumn 46, Issue 9, 2012, Pages

  Gilbar, Peter J ^a   Richmond, Joshua ^a   Wood, John ^a   Sullivan, Aimee ^a  

^a TOOWOOMBA HOSPITAL   (Australia)

Author keywords

Cyclophosphamide; Hyponatremia; Oral administration; SIADH

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FUROSEMIDE; MELPHALAN; OLMESARTAN; OMEPRAZOLE; PREDNISOLONE; SERTRALINE; SODIUM; SODIUM CHLORIDE; TEMAZEPAM; THALIDOMIDE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHEMOTHERAPY INDUCED EMESIS; DEPRESSION; DROWSINESS; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LETHARGY; MULTIPLE CYCLE TREATMENT; MYELOMA; MYOPATHY; PRIORITY JOURNAL; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; TREATMENT RESPONSE; WATER DEPRIVATION;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; INAPPROPRIATE ADH SYNDROME; MULTIPLE MYELOMA;

EID: 84865859826     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R296     Document Type: Article

References (36)

1. Emadi E, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 2009;6:639-647.
2. DeFronzo RA, Braine H, Colvin OM, Davis PJ. Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation. Ann Intern Med 1973;78:861-869.
3. Steele TH, Serpick AA, Block JG. Antidiuretic response to cyclophosphamide in man. J Pharmacol Exp Ther 1973;185:245-253.
4. DeFronzo RA, Colvin OM, Braine H, Robertson GL, Davis PJ. Cyclophosphamide and the kidney. Cancer 1974;33:483-491.
5. Lee YC, Park JS, Lee CH, et al. Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide. Nephrol Dial Transplant 2010;25: 1520-1524.
6. Munro AHG, Crompton GK. Inappropriate antidiuretic hormone secretion in oat-cell carcinoma of bronchus. Thorax 1972;27:640-642.
7. Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E. A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer 1979;44:896-898.
8. Bressler RB, Huston DP. Water intoxication following moderate-dose intravenous cyclophosphamide. Arch Intern Med 1985;145:548-549.
9. Haas A, Chin T, Stiehm ER. Cyclophosphamide-induced water intoxication: treatment with fluid restriction and 2-mercaptoethane sulfonate. Am J Dis Child 1986;140:1094-1095.
10. Webberley MJ, Murray JA. Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J 1989;65:950-952.
11. Dimopoulos MA, Delasalle KB, Champlin R, Alexanian R. Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma. Br J Haematol 1993;83:240-244.
12. McCarron MO, Wright GD, Roberts SD. Water intoxication after low dose cyclophosphamide. BMJ 1995;311:292.
13. Abe T, Takaue Y, Okamoto Y, et al. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in children undergoing high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Pediatr Hematol Oncol 1995;12:363-369.
14. Bjorck E, Samuelsson J. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) after treatment with cyclophosphamide, a-interferon and betamethasone in a patient with multiple myeloma. Eur J Haematol 1996;56:323-325.
15. Spital A, Ristow S. Cyclophosphamide induced water intoxication in a woman with Sjogren's syndrome. J Rheumatol 1997;24:2473-2475.
16. Chintanadilok J, Kallas H, Lowenthal DT. Lung cancer and drug-induced severe hyponatremia. Geriat Nephrol Urol 1998;8:161-5.
17. Campbell DM, Atkinson A, Gillis D, Sochett EB. Cyclophosphamide and water retention: mechanism revisited. J Pediatr Endocrinol Metab 2000;13:673-675.
18. Salido M, Macarron P, Hernandez-Garcia C, D'Cruz DP, Khamashta MA, Hughes GRV. Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus. Lupus 2003; 12:636-639.
19. Osier FHA, Berkley JA, Newton CRJC. Life-threatening hyponatraemia and neurotoxicity during chemotherapy for Burkitt's lymphoma. Trop Doct 2006;36:177-178.
20. Lazarevic V, Hagg E, Wahlin A. Hiccups and severe hyponatremia associated with high-dose cyclophosphamide in conditioning regimen for allogeneic stem cell transplantation. Am J Hematol 2007;82:8.
21. Berger AK, Bellos F, Siegmund A, Eisenbach C, Lordick F. Symptomatic hyponatraemia caused by cyclophosphamide. Onkologie 2009;32:280-282.
22. Jayachandran NV, Chandrasekhara PKS, Thomas J, Agrawal S, Narsimulu G. Cyclophosphamide-associated complications: we need to be aware of SIADH and central pontine myelinolysis. Rheumatology 2009; 48:89-90.
23. Natarajan K, Srinivas CR, Jayachandran K, Ramanathan R. Cyclophosphamide- induced syndrome of inappropriate antidiuretic hormone secretion. Indian J Dermatol Venereol Leprol 2009;75:629-630.
24. Bruining DM, van Roon EN, de Graaf H, Hoogendoorn M. Cyclophosphamide- induced symptomatic hyponatraemia. Neth J Med 2011;69: 192-194.
25. Ping WU, Davies FE, Horton C, et al. The combination of cyclophosphamide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide-vincristine-doxorubicin-methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis. Leuk Lymphoma 2006;47:2335-2338.
26. Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med 2007;356:2064-2072.
27. Hannon MJ, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. Eur J Endocrinol 2010; 162(suppl 1):S5-S12.
28. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer 2007;15:1341-1347.
29. Nanji AA. Multiple myeloma and syndrome of inappropriate secretion of antidiuretic hormone. South Med J 1983;76:270.
30. Sherlock M, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: current and future management options. Eur J Endocrinol 2010;162(suppl 1):S13-S18.
31. Vanhees SL, Paridaens R, Vansteenkiste JF. Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review. Ann Oncol 2000;11:1061-1065.
32. Hirata Y, Kokote T, Kobayashi K, et al. Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in a patient with peripheral T-cell lymphoma unspecified. Leuk Lymph 2009; 50:1226-1229.
33. Kirch C, Gachot B, Germann N, Blot F, Nitenberg G. Recurrent ifosfamide- induced hyponatraemia. Eur J Cancer 1997;33:2438-2439.
34. Kirby D, Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 2001;16:484-493.
35. Stewart DJ, Morgan LR Jr, Verma V, Maroun JA, Thibault M. Pharmacology, relative bioavailability, and toxicity of three different oral cyclophosphamide preparations in a randomized, cross-over study. Invest New Drugs 1005;13:99-107.
36. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.